Patient Receptiveness to Using Virtual Reality

NCT03528668 | Completed

• 1 other identifier: 2017P002788
• Study Type: observational
• Target: 89
• Locations: 1 country
• Sites: 1

Brief Summary

This study will evaluate the acceptability, use, and general effect that exposure to virtual reality has on hospitalized patients reporting at least one discomfort including recent or current moderate-severe pain.

Conditions

Pain; Anxiety

Outcome Measures

Primary Outcomes (1)

• Change in Pain

  Change in subjective report of pain measured on a visual analog scale

  Change between baseline and 5 minutes after intervention

Secondary Outcomes (2)

• Change in Heart Rate

  Change between baseline and 5 minutes after intervention

• Change in Anxiety

  Change between baseline and 5 minutes after intervention

Interventions

Virtual Reality Exposure DEVICE

Exposure to Virtual Reality program for up to 30 minutes

Eligibility Criteria

• Age: 20 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Inpatients on adult general care medical/surgical units, regardless of genders will be identified via an existing pain assessment dashboard that allows the investigator to identify patients with 3 or episodes of moderate-severe pain in the prior 24-hour period. The investigator will scan the report for potential subjects in accordance with participating units, inclusion and exclusion criteria. The front-line nurse manager and registered Nurse caring for to patient will be contacted for appropriateness to consider including and the timing when the patient can be approached without interrupting planned tests, treatments or workflow.

You may qualify if:

• English-speaking
• Inpatients on a general care unit
• Current or recorded moderate to severe pain in past 24 hours

You may not qualify if:

• Receiving palliative/end of life care;
• Admitted for treatment of psychiatric or mental health disorder
• History of seizure or stroke
• Legally blind or deaf
• Moderate or severe cognitive impairment
• Head wounds or bandages
• On isolation precautions.

Sponsors & Collaborators

• Massachusetts General Hospital: lead

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Conditions

Pain; Anxiety Disorders

Condition Hierarchy (Ancestors)

Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Mental Disorders

Study Officials

• Paul M Arnstein, PhD

  Massachusetts General Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Clinical Nurse Specialist

Study Record Dates

• First Submitted: April 23, 2018
• First Posted: May 18, 2018
• Study Start: April 16, 2018
• Primary Completion: October 12, 2018
• Study Completion: October 12, 2018
• Last Updated: February 24, 2021

Record last verified: 2021-02

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)